U.S. Markets close in 1 hr 12 mins
  • S&P 500

    4,591.21
    +24.21 (+0.53%)
     
  • Dow 30

    34,557.34
    +73.62 (+0.21%)
     
  • Nasdaq

    15,544.40
    +6.71 (+0.04%)
     
  • Russell 2000

    2,193.67
    -5.24 (-0.24%)
     
  • Crude Oil

    65.82
    -0.36 (-0.54%)
     
  • Gold

    1,781.70
    +5.20 (+0.29%)
     
  • Silver

    22.30
    -0.52 (-2.28%)
     
  • EUR/USD

    1.1324
    -0.0015 (-0.1359%)
     
  • 10-Yr Bond

    1.4490
    +0.0060 (+0.42%)
     
  • Vix

    25.70
    -1.49 (-5.48%)
     
  • GBP/USD

    1.3279
    -0.0022 (-0.1673%)
     
  • USD/JPY

    112.8570
    -0.3230 (-0.2854%)
     
  • BTC-USD

    57,527.52
    -138.61 (-0.24%)
     
  • CMC Crypto 200

    1,468.84
    -0.24 (-0.02%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today

·4 min read
If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

CRISPR Therapeutics (NASDAQ: CRSP) is one of the most exciting biotechs on the market today, because it's pushing the limits of what is possible when it comes to treating hereditary diseases. As the flagship program, it's not an exaggeration to say that CRISPR's success was in large part riding on CTX001, so the stock would have been ripe for speculators -- and it still is.